Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-16-543484
Filing Date
2016-04-18
Accepted
2016-04-15 19:32:24
Documents
10

Document Format Files

Seq Description Document Type Size
1 S-3 d161470ds3.htm S-3 272035
2 EX-4.9 d161470dex49.htm EX-4.9 106260
3 EX-4.10 d161470dex410.htm EX-4.10 106560
4 EX-4.11 d161470dex411.htm EX-4.11 99972
5 EX-4.12 d161470dex412.htm EX-4.12 301547
6 EX-5.1 d161470dex51.htm EX-5.1 25723
7 EX-12.1 d161470dex121.htm EX-12.1 21761
8 EX-23.1 d161470dex231.htm EX-23.1 1888
9 GRAPHIC g161470g38c99.jpg GRAPHIC 40787
10 GRAPHIC g161470g61n67.jpg GRAPHIC 6254
  Complete submission text file 0001193125-16-543484.txt   1001714
Mailing Address 25134 RYE CANYON LOOP SUITE 300 VALENCIA CA 91355
Business Address 25134 RYE CANYON LOOP SUITE 300 VALENCIA CA 91355 6617755300
MANNKIND CORP (Filer) CIK: 0000899460 (see all company filings)

EIN.: 133607736 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-210792 | Film No.: 161575580
SIC: 2834 Pharmaceutical Preparations